Sort
51,570 grants matching “autoimmune disease”
Calcium Signaling in Health and Disease
$3,816,281Anant Parekh · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Proteasome Targeting for Alloreactive Plasma Cells
$3,810,794David M Allman · University Of Pennsylvania · R01 · FY2025 · AI
STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY
$3,794,731Victor Johnson · · N01 · FY2017 · ES
Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells
$3,771,076Ethan M. Shevach · Niaid Extramural Activities · Z01 · FY2007 · AI
Program in Clinical Research, Clinical Support Services and Clinical Training
$3,759,127Janet Hall · National Institute Of Environmental Health Sciences · ZID · FY2021 · ES
Mice with autologous human T1D-derived immune systems and iPSC-derived beta cells
$3,750,944Megan Sykes · Columbia University Health Sciences · UC4 · FY2014 · DK
Transcriptional Functions of Nuclear Receptors in Cancer Cells
$3,729,190Trevor K Archer · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$3,721,148Rachel R. Caspi · National Eye Institute · Z01 · FY2007 · EY
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$3,720,450Rachel R. Caspi · National Eye Institute · ZIA · FY2020 · EY
GENERAL CLINICAL RESEARCH CENTER
$3,709,969University Of Colorado Denver · M01 · FY2000 · RR
Benaroya Research Institute/UCDHSC Autoimmune Cooperative Study Group
$3,707,647George S Eisenbarth · University Of Colorado Denver · U19 · FY2006 · AI
Autoimmune Diseases Group
$3,707,136Lynette Keyes-Elstein · Rho Federal Systems Division, Inc. · UM2 · FY2016 · AI
Cytokine Signaling, Immunoregulation and Autoimmune and Immunodeficiency Diseases
$3,704,363John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY
$3,703,659Victor Johnson · · N01 · FY2016 · ES
Coordinating Center for Organ Transplant Clinical Trials (U01)
$3,703,211David N. Ikle · Rho Federal Systems Division, Inc. · U01 · FY2012 · AI
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core
$3,700,000Joel Marvin Guthridge · Oklahoma Medical Research Foundation · UC2 · FY2024 · AR
High-resolution analysis of juvenile human pancreas maturation
$3,700,000Christopher V. Wright · Vanderbilt University · UC4 · FY2015 · DK
Transplantation Group
$3,685,667David N. Ikle · Rho Federal Systems Division, Inc. · UM2 · FY2015 · AI
Lupus Clinical Trials
$3,661,767Sarfaraz Hasni · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
Regulation of B cell Responses in SLE and Other Autoimmune Diseases
$3,653,750Ignacio E. Sanz · Emory University · U19 · FY2024 · AI
Regulation of B cell Responses in SLE and Other Autoimmune Diseases
$3,653,748Ignacio E. Sanz · Emory University · U19 · FY2025 · AI
Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure
$3,641,961Johnnye L Lewis · University Of New Mexico Health Scis Ctr · UG3 · FY2017 · OD
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$3,638,367Stacey Lynn Clardy · University Of Utah · U01 · FY2024 · NS
Systemic Autoimmunity
$3,637,839Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Advancing Transplantation Tolerance in Nonhuman Primates
$3,635,295Andrew B Adams · University Of Minnesota · U19 · FY2025 · AI